In contrast, the increase was much larger for the ISUP ≥ 2 prostate cancer, where only 3% of the men with PSA level 2–3 ng/mL were diagnosed with ISUP ≥ 2 cancer compared to 13% among the men with PSA level 10–15 ng/mL. The gene discussed is KLK3; the disease is prostate cancer.